Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs

References

• Nett JE. Candida auris: an emerging pathogen “incognito”? PLoS Pathog. 2019;15:e1007638.
   PubMed Web of Science ®Google Scholar
• Sears D, Schwartz BS. Candida auris: an emerging multidrug-resistant pathogen. Inter J Infect Dis. 2017;63:95–98.
   PubMed Web of Science ®Google Scholar
• CDC. Antibiotic resistance threats in the United States. Atlanta (GA): U.S. Department of Health and Human Services, Antibiotic Resistance Threats in the United States; 2019. (Accessed on 18 April 2020). Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
   Google Scholar
• Eldesouky HE, Li X, Abutaleb NS, et al. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris. Int J Antimicrob Agents. 2018;52:754–761.
   PubMed Web of Science ®Google Scholar
• CDC. Antifungal susceptibility and resistance breakpoints in Candida auris; 2020. (Accessed on 18 April 2020). Available from: https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html
   Google Scholar
• Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31. DOI:https://doi.org/10.1128/CMR.00029-17
   Google Scholar
• Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13:e1006290.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Woodworth K, Walters M, et al. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2019;57:1–12.
   PubMed Web of Science ®Google Scholar
• Mohammad H, Elghazawy NH, Eldesouky HE, et al. Discovery of a novel dibromoquinoline compound exhibiting potent antifungal and antivirulence activity that targets metal ion homeostasis. ACS Infect Dis. 2018;4:403–414.
   PubMed Web of Science ®Google Scholar
• Haegler P, Joerin L, Krahenbuhl S, et al. Hepatocellular toxicity of imidazole and triazole antimycotic agents. Toxicol Sci. 2017;157:183–195.
   PubMed Web of Science ®Google Scholar
• Eldesouky HE, Mayhoub A, Hazbun TR, et al. Reversal of azole resistance in Candida albicans by sulfa antibacterial drugs. Antimicrob Agents Chemother. 2018;62. DOI:https://doi.org/10.1128/AAC.00701-17
   Google Scholar
• Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev. 1999;12:40–79.
   PubMed Web of Science ®Google Scholar
• Lewis RE. Current concepts in antifungal pharmacology. Mayo Clin Proc. 2011;86:805–817.
   PubMed Web of Science ®Google Scholar
• Allen D, Wilson D, Drew R, et al. Azole antifungals: 35 years of invasive fungal infection management. Expert Rev Anti Infect Ther. 2015;13:787–798.
   PubMed Web of Science ®Google Scholar
• Zavrel M, Esquivel BD, White TC. The ins and outs of azole antifungal drug resistance: molecular mechanisms of transport. In: Gotte M, Berghuis A, Matlashewski G, et al., editors. Handbook of antimicrobial resistance. New York (NY): Springer; 2014:1.
   Google Scholar
• Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist. 2017;10:249–259.
   PubMed Web of Science ®Google Scholar
• Whaley SG, Berkow EL, Rybak JM, et al. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2016;7:2173.
   PubMed Web of Science ®Google Scholar
• Worthington RJ, Melander C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 2013;31:177–184.
   PubMed Web of Science ®Google Scholar
• Chiang CY, Uzoma I, Moore RT, et al. Mitigating the impact of antibacterial drug resistance through host-directed therapies: current progress, outlook, and challenges. mBio. 2018;9. DOI:https://doi.org/10.1128/mBio.01932-17
   Google Scholar
• Pizzorno A, Padey B, Terrier O, et al. Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy. Front Immunol. 2019;10:531.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Qasim M, et al. Nanoparticle-mediated combination therapy: two-in-one approach for cancer. Int J Mol Sci. 2018;19:3264.
   Web of Science ®Google Scholar
• Gu WR, Guo DM, Zhang LP, et al. The synergistic effect of azoles and fluoxetine against resistant Candida albicans strains is attributed to attenuating fungal virulence. Antimicrob Agents Ch. 2016;60:6179–6188.
   PubMed Web of Science ®Google Scholar
• Sun LM, Liao K, Liang S, et al. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans. J Appl Microbiol. 2015;118:826–838.
   PubMed Web of Science ®Google Scholar
• Chen YL, Lehman VN, Averette AF, et al. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. Plos One. 2013;8:e57672.
   PubMed Web of Science ®Google Scholar
• Silva LV, Sanguinetti M, Vandeputte P, et al. Milbemycins: more than efflux inhibitors for fungal pathogens. Antimicrob Agents Chemother. 2013;57(2):873–886.
   PubMed Web of Science ®Google Scholar
• Mohammad H, Eldesouky HE, Hazbun T, et al. Identification of a phenylthiazole small molecule with dual antifungal and antibiofilm activity against Candida albicans and Candida auris. Sci Rep. 2019;9:18941.
   PubMed Web of Science ®Google Scholar
• Thangamani S, Eldesouky HE, Mohammad H, et al. Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells. Biochim Biophys Acta Gen Subj. 2017;1861:3002–3010.
   PubMed Web of Science ®Google Scholar
• Mohammad H, Kyei-Baffour K, Younis W, et al. Investigation of aryl isonitrile compounds with potent, broad-spectrum antifungal activity. Bioorg Med Chem. 2017;25:2926–2931.
   PubMed Web of Science ®Google Scholar
• Scorneaux B, Angulo D, Borroto-Esoda K, et al. SCY-078 is fungicidal against candida species in time-kill studies. Antimicrob Agents Chemother. 2017;61. DOI:https://doi.org/10.1128/AAC.01961-16
   Google Scholar
• Chang W, Liu J, Zhang M, et al. Efflux pump-mediated resistance to antifungal compounds can be prevented by conjugation with triphenylphosphonium cation. Nat Commun. 2018;9:5102.
   PubMed Web of Science ®Google Scholar
• Kubiczek D, Raber H, Gonzalez-García M, et al. Derivates of the antifungal peptide Cm-p5 inhibit development of Candida auris biofilms in vitro. Antibiotics (Basel). 2020;9. DOI:https://doi.org/10.3390/antibiotics9070363
   Google Scholar
• Lara HH, Ixtepan-Turrent L, Jose Yacaman M, et al. Inhibition of Candida auris biofilm formation on medical and environmental surfaces by silver nanoparticles. ACS Appl Mater Interfaces. 2020;12:21183–21191.
   PubMed Web of Science ®Google Scholar
• Dominguez EG, Zarnowski R, Choy HL, et al. Conserved role for biofilm matrix polysaccharides in Candida auris drug resistance. mSphere. 2019;4. DOI:https://doi.org/10.1128/mSphereDirect.00680-18
   Google Scholar
• Chen S, Zhou Y, Chen Y, et al. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–i890.
   PubMed Web of Science ®Google Scholar
• Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357–360.
   PubMed Web of Science ®Google Scholar
• Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140.
   PubMed Web of Science ®Google Scholar
• Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.
   PubMed Web of Science ®Google Scholar
• Benjamini YH. Yosef Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.
   Google Scholar
• Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–3402.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284–287.
   PubMed Web of Science ®Google Scholar
• Chau AS, Mendrick CA, Sabatelli FJ, et al. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob Agents Chemother. 2004;48:2124–2131.
   PubMed Web of Science ®Google Scholar
• Eldesouky HE, Salama EA, Hazbun TR, et al. Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities. Sci Rep. 2020;10:6089.
   PubMed Web of Science ®Google Scholar
• Thangamani S, Maland M, Mohammad H, et al. Repurposing approach identifies auranofin with broad spectrum antifungal activity that targets Mia40-Erv1 pathway. Front Cell Infect Microbiol. 2017;7:4.
   PubMed Web of Science ®Google Scholar
• Thangamani S, Mohammad H, Abushahba MFN, et al. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Sci Rep. 2015;5(1):16407.
   PubMedGoogle Scholar
• Eldesouky HE, Salama EA, Li X, et al. Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species. Sci Rep. 2020;10(1):7525.
   PubMed Web of Science ®Google Scholar
• Andes D. Optimizing antifungal choice and administration. Curr Med Res Opin. 2013;29(Suppl 4):13–18.
   PubMedGoogle Scholar
• Graybill JR, Burgess DS, Hardin TC. Key issues concerning fungistatic versus fungicidal drugs. Eur J Clin Microbiol Infect Dis. 1997;16:42–50.
   PubMed Web of Science ®Google Scholar
• Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17:255–267.
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Johnson AD. Candida albicans biofilms and human disease. Annu Rev Microbiol. 2015;69:71–92.
   PubMed Web of Science ®Google Scholar
• Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006;6:979–986.
   PubMed Web of Science ®Google Scholar
• Cavalheiro M, Teixeira MC. Candida biofilms: threats, challenges, and promising strategies. Front Med (Lausanne). 2018;5:28.
   PubMed Web of Science ®Google Scholar
• Wuyts J, Van Dijck P, Holtappels M. Fungal persister cells: the basis for recalcitrant infections? Plos Pathog. 2018;14:ARTN e1007301.
   Web of Science ®Google Scholar
• Valasatava Y, Rosato A, Furnham N, et al. To what extent do structural changes in catalytic metal sites affect enzyme function? J Inorg Biochem. 2018;179:40–53.
   PubMed Web of Science ®Google Scholar
• Riordan JF. The role of metals in enzyme activity. Ann Clin Lab Sci. 1977;7:119–129.
   PubMed Web of Science ®Google Scholar
• Andreini C, Bertini I, Cavallaro G, et al. Metal ions in biological catalysis: from enzyme databases to general principles. J Biol Inorg Chem. 2008;13:1205–1218.
   PubMed Web of Science ®Google Scholar
• De Cremer K, De Brucker K, Staes I, et al. Stimulation of superoxide production increases fungicidal action of miconazole against Candida albicans biofilms. Sci Rep. 2016;6:27463.
   PubMed Web of Science ®Google Scholar
• Delattin N, Cammue BP, Thevissen K. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med Chem. 2014;6:77–90.
   PubMed Web of Science ®Google Scholar
• Tamura M, Cueno ME, Abe K, et al. Ions released from a S-PRG filler induces oxidative stress in Candida albicans inhibiting its growth and pathogenicity. Cell Stress Chaperones. 2018;23:1337–1343.
   PubMed Web of Science ®Google Scholar
• Tewari RK, Hadacek F, Sassmann S, et al. Iron deprivation-induced reactive oxygen species generation leads to non-autolytic PCD in Brassica napus leaves. Environ Exp Bot. 2013;91:74–83.
   PubMed Web of Science ®Google Scholar
• Bystrom LM, Guzman ML, Rivella S. Iron and reactive oxygen species: friends or foes of cancer cells? Antioxid Redox Signal. 2014;20:1917–1924.
   PubMed Web of Science ®Google Scholar
• Jorda T, Puig S. Regulation of ergosterol biosynthesis in saccharomyces cerevisiae. Genes (Basel). 2020;11. DOI:https://doi.org/10.3390/genes11070795
   Google Scholar
• Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2000;44:2693–2700.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhou M, Wang W, et al. Abnormal Ergosterol biosynthesis activates transcriptional responses to antifungal azoles. Front Microbiol. 2018;9:9.
   PubMed Web of Science ®Google Scholar
• Fiori A, Van Dijck P. Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis. Antimicrob Agents Chemother. 2012;56:3785–3796.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kakeya H, Miyazaki T, et al. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis. Jpn J Infect Dis. 2011;64:292–296.
   PubMed Web of Science ®Google Scholar
• Prasad T, Chandra A, Mukhopadhyay CK, et al. Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells. Antimicrob Agents Chemother. 2006;50:3597–3606.
   PubMed Web of Science ®Google Scholar
• Hameed S, Dhamgaye S, Singh A, et al. Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans. PLoS One. 2011;6:e18684.
   PubMed Web of Science ®Google Scholar